72626-2601 : Ledipasvir and Sofosbuvir Oral Tablet, Film Coated


NDC72626-2601
Labeler: Asegua Therapeutics LLC
Product Type: Human Prescription Drug
Drug Name:  Ledipasvir and Sofosbuvir
Dosage Form: Oral Tablet, Film Coated
Application #: NDA205834
Rev. Date: 


Appearance:


Markings: ASE;9875
Shapes:  Diamond (4 sides)
Colors:  Orange
Size (mm): 20
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 72626-2601-1: 2 BLISTER PACK IN 1 CARTON (72626‑2601‑1) > 14 TABLET, FILM COATED IN 1 BLISTER PACK

Active Ingredients:

  • Ledipasvir
  • Sofosbuvir

Dosage Strength:

  • 90 mg
  • 400 mg

Inactive Ingredients:

  • Alcohol
  • Copovidone K25-31
  • Lactose Monohydrate
  • Microcrystalline Cellulose
  • Silicon Dioxide
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Water
  • Titanium Dioxide
  • Polyethylene Glycol 3350
  • Talc
  • Fd&c Yellow No. 6
  • Polyvinyl Alcohol, Unspecified /

Pharmaceutical Classes:

  • Hepatitis C Virus NS5A Inhibitor [EPC]
  • P-Glycoprotein Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
  • RNA Replicase Inhibitors [MoA]
  • Nucleoside Analog [EXT]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72626-2601 QR Code

< Prev: 72625-135Next: 72626-2701 >

Related Discussions:

Which is the efficiency of the Ledipasvir + Sofosbuvir?
Please, be so kind and tell me if you have some reference about "LEDVIR", do you think that this medicine could ...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.